Eason Technology Limited Receives Notification from NYSE Regarding Delinquent Filing of its Semi-annual Financials

Eason Technology (NYSE: DXF) received notice from NYSE Regulation that it failed to timely file its Form 6-K containing semi-annual financials for the period ended June 30, 2025, missing the Dec 31, 2025 filing deadline.

Rhea-AI Summary

Eason Technology (NYSE: DXF) received notice from NYSE Regulation that it failed to timely file its Form 6-K containing semi-annual financials for the period ended June 30, 2025, missing the Dec 31, 2025 filing deadline. The company said the delay resulted from completing its financial statements and that it is working to file the Interim Report within the Initial Cure Period through June 30, 2026. ADSs remain listed and tradable during the cure period, but failure to cure could lead to suspension and delisting or a possible additional cure period to Dec 31, 2026.

Positive

• ADSs remain listed and tradable during the cure period
• Company is actively working to file the Interim Report within the cure period

Negative

• Failed to file Form 6-K for half year ended June 30, 2025
• Subject to NYSE American delisting procedures if noncompliant after cure periods
• Initial Cure Period ends June 30, 2026; additional cure to Dec 31, 2026 possible

Argus Jan 9 session

-8.44% close to close Open Argus

Details

News Market Reaction – DXF

In the Jan 9 session, DXF declined 8.44%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -8.4% in the session following this news. A negative reaction despite prior rebounds...

Analysis

The stock moved -8.4% in the session following this news. A negative reaction despite prior rebounds on NYSE compliance headlines would fit DXF’s fragile backdrop. The company had already received a non-compliance letter tied to low equity and losses and regained compliance only recently with a going concern emphasis noted by auditors. A fresh delinquent filing notice extending cure periods to as late as December 31, 2026 may have reinforced concerns over reporting controls and listing risk.

Key Figures

Filing due date: December 31, 2025 Interim period end: June 30, 2025 Initial cure period end: June 30, 2026 +3 more

Filing due date

December 31, 2025

Deadline for Form 6-K semi-annual financials

Interim period end

June 30, 2025

Half-year period covered by delinquent report

Initial cure period end

June 30, 2026

Six-month NYSE American Initial Cure Period

Additional cure period end

December 31, 2026

Potential Additional Cure Period endpoint

Current price

$2.25

Pre-news trading level vs. listing risk disclosure

52-week range

$0.071–$48.26

Shows extreme volatility over the past year

Historical Context

4 past events · Latest: Oct 20

4 events

1. Oct 20

   NYSE non-compliance

   24h Move

   +3.5%

   Notice of noncompliance due to low equity and multi-year losses.

2. Oct 08

   Equity incentives

   24h Move

   -2.1%

   Issuance of incentive ADSs and lock-up commitment by management.

3. Sep 26

   Compliance regained

   24h Move

   -31.1%

   Regained NYSE compliance but with auditor going concern emphasis.

4. Sep 24

   Annual report filing

   24h Move

   -1.0%

   Form 20-F filing providing audited 2024 financial statements.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

form 6-k, nyse american, ads

3 terms

form 6-k regulatory

"file its Form 6-K containing semi-annual financial information"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

nyse american regulatory

"continued listing standards of NYSE American LLC"

NYSE American is a stock exchange where companies can list their shares to be bought and sold by investors. It functions like a marketplace, helping businesses raise money and providing investors with opportunities to buy ownership in these companies. Its role is important because it facilitates the trading of smaller or emerging companies, offering investors access to a broader range of investment options.

ads financial

"no immediate impact on the listing of the Company's ADSs, which will continue"

Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HONG KONG, Jan. 9, 2026 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE: DXF) today announced that on January 2, 2025, it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC ("NYSE American" or the "Exchange"). The Company failed to timely file its Form 6-K containing semi-annual financial information for the half year period ended June 30, 2025 (the "Interim Report") by the filing due date of December 31, 2025 (the "Filing Delinquency"). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide.

NYSE Regulation notified the Company that NYSE American will closely monitor the status of the Company's Interim Report and any subsequent delayed filings for a six-month period from the date of the Filing Delinquency until June 30, 2026 (the "Initial Cure Period"). If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the Company's securities to be traded for up to an additional six-month period until December 31, 2026 (the "Additional Cure Period") depending on the Company's specific circumstances. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 hereof. If the Exchange determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file the Interim Report and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.

The Company was not able to, without unreasonable effort or expense, to make the required filing by December 31, 2025, as a result of a delay in completing its financial statements for the half year ended June 30, 2025. The Company is making all efforts to file the Interim Report as soon as possible and within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.

This delinquency notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

About Eason Technology Limited

Eason Technology Limited is a company engaged in real estate operation management and investment and digital technology security business in Hong Kong, China. The Company was formerly a licensed microfinance lender serving individuals and SMEs in Hubei Province, China, but has suspended offering loans to its customers since 2020.

Safe Harbor Statement

Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.

 

View original content:https://www.prnewswire.com/news-releases/eason-technology-limited-receives-notification-from-nyse-regarding-delinquent-filing-of-its-semi-annual-financials-302657515.html

SOURCE Eason Technology Limited

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What filing did Eason Technology (DXF) miss and for what period?

Eason Technology missed its Form 6-K containing semi-annual financials for the period ended June 30, 2025.

Will Eason Technology ADSs (DXF) stop trading after the delinquency notice?

No; ADSs will remain listed and tradable during the cure period, subject to other listing requirements.

How long is the NYSE Initial Cure Period for DXF to regain compliance?

The Initial Cure Period runs until June 30, 2026 from the filing delinquency date.

What happens if DXF does not file by June 30, 2026?

The Exchange may grant an additional cure period to Dec 31, 2026 or commence suspension and delisting procedures.

Why did Eason Technology fail to file the Interim Report by Dec 31, 2025?

The company cited a delay in completing its financial statements and said filing without unreasonable effort or expense was not possible by the deadline.

Does the NYSE notice mean DXF is already delisted?

No; the notice indicates noncompliance but does not immediately affect listing while cure periods are active.